Partner news
News
Partner news
Mestag Therapeutics announces collaboration with Janssen, focused on the discovery of novel fibroblast targets for the treatment of inflammatory disease
Read full storyPartner news
L'engagement de Janssen France dans l'IA et la génomique
Read full storyPartner news
Collaboration with Johnson & Johnson Innovation to jump-start search for new malaria drugs
Read full storyPartner news
Teneobio Announces Achievement of Milestone Payment as Janssen Advances Phase I Study of Bispecific JNJ-75348780 for the Treatment of NHL and CLL
Read full storyPartner news
Cidara Therapeutics Announces Agreement with Janssen to Develop and Commercialize AVCs for the Prevention and Treatment of Influenza
Read full storyPartner news
Oxford to collaborate with Janssen to map the cellular landscape of immune mediated disorders
Read full storyPartner news
Adicet Bio, Inc. Announces Pricing of $135 Million Public Offering of Common Stock and Concurrent Private Placement
Read full storyPartner news
Exonate announces the initiation of Phase Ib/II clinical trial for Diabetic Macular Oedema, as part of its collaboration with Janssen
Read full storyPartner news
£10 million research collaboration to detect lung cancer earlier
Read full storyPartner news
Revitope Oncology Announces Strategic Collaboration with Janssen to Leverage its Unique T Cell Engager Platform
Read full storyPartner news
Morphic Expands Research and Development Collaboration with Janssen Through Third Integrin Program
Read full storyPartner news
MacroGenics Enters Research Collaboration with Janssen to Develop Novel DART® Molecule
Read full storyPartner news
Australian National University Announces Research Project with Janssen to Help Develop New Methods for Measuring and Monitoring Type 1 Diabetes
Read full storyPartner news